POLBF (Poolbeg Pharma) Cash Ratio : 17.93 (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Poolbeg Pharma Cash Ratio?

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Poolbeg Pharma's Cash Ratio for the quarter that ended in Jun. 2024 was 17.93.

Poolbeg Pharma has a Cash Ratio of 17.93. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Poolbeg Pharma's Cash Ratio or its related term are showing as below:

POLBF' s Cash Ratio Range Over the Past 10 Years
Min: 12.34 Med: 20.39 Max: 47.83
Current: 17.93

During the past 3 years, Poolbeg Pharma's highest Cash Ratio was 47.83. The lowest was 12.34. And the median was 20.39.

POLBF's Cash Ratio is ranked better than
92.37% of 1468 companies
in the Biotechnology industry
Industry Median: 2.71 vs POLBF: 17.93

Poolbeg Pharma Cash Ratio Historical Data

The historical data trend for Poolbeg Pharma's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Cash Ratio Chart

Poolbeg Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Cash Ratio

47.87

16.76

12.34

Poolbeg Pharma Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Cash Ratio	Get a 7-Day Free Trial			22.86	16.76	27.64	12.34	17.93

Competitive Comparison of Poolbeg Pharma's Cash Ratio

For the Biotechnology subindustry, Poolbeg Pharma's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poolbeg Pharma's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poolbeg Pharma's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Poolbeg Pharma's Cash Ratio falls into.

Save Embed

;

Save Embed

;

Poolbeg Pharma Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Poolbeg Pharma's Cash Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash Ratio (A: Dec. 2023 )	=	Cash, Cash Equivalents, Marketable Securities	/	Total Current Liabilities
	=	15.406	/	1.248
	=	12.34

Poolbeg Pharma's Cash Ratio for the quarter that ended in Jun. 2024 is calculated as:

Cash Ratio (Q: Jun. 2024 )	=	Cash, Cash Equivalents, Marketable Securities	/	Total Current Liabilities
	=	12.8	/	0.714
	=	17.93

Poolbeg Pharma (OTCPK:POLBF) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.

Poolbeg Pharma Cash Ratio Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Poolbeg Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (OTCPK:POLBF) » Definitions » Cash Ratio

Comparable Companies

Traded in Other Exchanges

POLB:UK 7JN:Germany

Address

42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.poolbegpharma.com

Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.